Development Level

Tchem 7 | 1,890
Tbio 4 | 10,625

Disease

Cancer 8 | 2,346
lung cancer 6 | 4,473
ovarian cancer 6 | 8,492
psoriasis 6 | 6,685
lung adenocarcinoma 5 | 2,714
osteosarcoma 5 | 7,933
Colorectal Neoplasms 4 | 217
Endometriosis 4 | 535
Mammary Neoplasms 4 | 410
Prostatic Neoplasms 4 | 471
interstitial cystitis 4 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
medulloblastoma, large-cell 4 | 6,234
Asthma 3 | 349
Breast cancer 3 | 3,099
Contact Dermatitis 3 | 80
Liver diseases 3 | 66
Lung Neoplasms 3 | 171
Precursor Cell Lymphoblastic Leukemia Lymphoma 3 | 42
Squamous cell carcinoma 3 | 96
acute quadriplegic myopathy 3 | 1,157
group 4 medulloblastoma 3 | 1,875
lung carcinoma 3 | 2,844
malignant mesothelioma 3 | 3,163
non-small cell lung cancer 3 | 2,798
oligodendroglioma 3 | 2,849
pancreatic cancer 3 | 2,300
subependymal giant cell astrocytoma 3 | 2,287
tuberculosis 3 | 1,563
Adenoma 2 | 165
Amphetamine-Related Disorders 2 | 74
Anemia 2 | 252
Atopic dermatitis 2 | 944
Bladder Neoplasm 2 | 109
Cardiomegaly 2 | 66
Chronic Obstructive Airway Disease 2 | 47
Diabetes Mellitus, Experimental 2 | 106
Diabetes Mellitus, Non-Insulin-Dependent 2 | 161
Liver Cirrhosis, Experimental 2 | 108
Liver carcinoma 2 | 217
Liver disease 2 | 219
Lung Injury 2 | 20
Male infertility 2 | 170
Micronuclei, Chromosome-Defective 2 | 20
Occupational Diseases 2 | 8
Parkinson Disease 2 | 105
Renal Cell Carcinoma 2 | 199
Schizophrenia 2 | 503
Toxic encephalopathy 2 | 131
adrenocortical carcinoma 2 | 1,427
astrocytic glioma 2 | 2,241
atypical teratoid/rhabdoid tumor 2 | 1,095
diabetes mellitus 2 | 1,663
gastric carcinoma 2 | 832
glioblastoma 2 | 5,572
group 3 medulloblastoma 2 | 2,254
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
invasive ductal carcinoma 2 | 2,950
nasopharyngeal carcinoma 2 | 1,056
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
pediatric high grade glioma 2 | 2,712
posterior fossa group A ependymoma 2 | 1,511
primary pancreatic ductal adenocarcinoma 2 | 1,271
substance-related disorder 2 | 105
ulcerative colitis 2 | 2,087
Adverse reaction to drug 1 | 54
Barrett's esophagus 1 | 185
Blindness 1 | 84
COPD 1 | 116
Cardiovascular system disease 1 | 194
Corneal disease 1 | 32
Dermatologic disorders 1 | 65
Drug Eruptions 1 | 18
Drug allergy 1 | 36
Drug-Induced Liver Injury 1 | 118
Gaucher disease type 1 1 | 171
Glaucoma 1, open angle, A 1 | 3
Glaucoma 3, primary congenital, A 1 | 2
Hypersensitivity 1 | 63
Inflammation 1 | 109
Kidney Diseases 1 | 86
Kidney Neoplasm 1 | 27
Liver neoplasms 1 | 109
Melanoma 1 | 261
Mesothelioma 1 | 40
Neural Tube Defects 1 | 31
Pain agnosia 1 | 99
Primary open angle glaucoma juvenile onset 1 1 | 2
Raynaud disease 1 | 6
Testicular germ cell tumor 1 | 23
Urinary bladder cancer 1 | 34
fascioscapulohumeral muscular dystrophy 1 | 100
interstitial lung disease 1 | 292
limb girdle muscular dystrophy 2B 1 | 74
ovarian neoplasm 1 | 97
primary congenital glaucoma 1 | 5
primary open angle glaucoma 1 | 12
uncontrolled asthma 1 | 67

Tissue

Blood and immune system 11 | 17,995
Digestive Tract 11 | 18,473
Liver and Pancreas 11 | 18,136
Urinary Tract 11 | 18,444
Cardiovascular System 10 | 17,958
Endocrine System 10 | 18,512
Female tissues 10 | 18,647
Male tissues 10 | 17,969
Nervous System 10 | 18,561
Respiratory system 10 | 17,484
Skin and soft tissues 10 | 18,115

Target Family

Enzyme 7 | 4,146
Non-IDG 4 | 11,969

Grant Application

5P42ES004908-13 11 | 11
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Quinone oxidoreductase CRYZ Tchem Enzyme -2.65492 344.7 60
Cytochrome P450 1A1 CYP1A1 Tchem Non-IDG -3.53853 3553.5 340
NAD(P)H dehydrogenase [quinone] 1 NQO1 Tchem Enzyme -3.08743 1230.1 502
Complement decay-accelerating factor CD55 Tbio Non-IDG -3.03379 1054.4 786
Glutathione S-transferase Mu 1 GSTM1 Tbio Enzyme -3.27011 1954.9 331
Adenine phosphoribosyltransferase APRT Tbio Enzyme -2.36029 222.4 220
Cytochrome P450 1B1 CYP1B1 Tchem Non-IDG -2.91993 863.4 217
Phospholipase A-2-activating protein PLAA Tchem Enzyme -1.87715 81.5 232
UDP-glucuronosyltransferase 1-8 UGT1A8 Tbio Enzyme -1.66143 41.8 3
Hematopoietic prostaglandin D synthase HPGDS Tchem Enzyme -3.72716 4165.3 68